{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:53:22Z","timestamp":1740135202261,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5T32GM007250"],"award-info":[{"award-number":["5T32GM007250"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"DOI":"10.1186\/s12859-024-05932-1","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T19:01:58Z","timestamp":1727463718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LOCC: a novel visualization and scoring of cutoffs for continuous variables with hepatocellular carcinoma prognosis as an example"],"prefix":"10.1186","volume":"25","author":[{"given":"George","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Letterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"5932_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2288-12-21","volume":"12","author":"C Bennette","year":"2012","unstructured":"Bennette C, Vickers A. Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents. BMC Med Res Methodol. 2012;12:21.","journal-title":"BMC Med Res Methodol"},{"issue":"34","key":"5932_CR2","doi-asserted-by":"publisher","first-page":"36308","DOI":"10.18632\/oncotarget.6121","volume":"6","author":"KH Eng","year":"2015","unstructured":"Eng KH, Schiller E, Morrell K. On representing the prognostic value of continuous gene expression biomarkers with the restricted mean survival curve. Oncotarget. 2015;6(34):36308\u201318.","journal-title":"Oncotarget"},{"issue":"2","key":"5932_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"8","key":"5932_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, et al. 70-Gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med. 2016;375(8):717\u201329.","journal-title":"N Engl J Med"},{"issue":"9361","key":"5932_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(03)12775-4","volume":"361","author":"N Iizuka","year":"2003","unstructured":"Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet. 2003;361(9361):923\u20139.","journal-title":"Lancet"},{"issue":"1","key":"5932_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2011.07.007","volume":"56","author":"JU Marquardt","year":"2012","unstructured":"Marquardt JU, Galle PR, Teufel A. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol. 2012;56(1):267\u201375.","journal-title":"J Hepatol"},{"issue":"3","key":"5932_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.20375","volume":"40","author":"JS Lee","year":"2004","unstructured":"Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40(3):667\u201376.","journal-title":"Hepatology"},{"issue":"9","key":"5932_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jclinepi.2010.02.018","volume":"63","author":"K Kim","year":"2010","unstructured":"Kim K, Zakharkin SO, Allison DB. Expectations, validity, and reality in gene expression profiling. J Clin Epidemiol. 2010;63(9):950\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"5932_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/gutjnl-2018-316408","volume":"68","author":"R Pinyol","year":"2019","unstructured":"Pinyol R, Montal R, Bassaganyas L, Sia D, Takayama T, Chau GY, Mazzaferro V, Roayaie S, Lee HC, Kokudo N, et al. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial. Gut. 2019;68(6):1065\u201375.","journal-title":"Gut"},{"issue":"3","key":"5932_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/cells10030648","volume":"10","author":"Y Qian","year":"2021","unstructured":"Qian Y, Daza J, Itzel T, Betge J, Zhan T, Marm\u00e9 F, Teufel A. Prognostic cancer gene expression signatures: current status and challenges. Cells. 2021;10(3):648.","journal-title":"Cells"},{"issue":"12","key":"5932_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"J Budczies","year":"2012","unstructured":"Budczies J, Klauschen F, Sinn BV, Gy\u0151rffy B, Schmitt WD, Darb-Esfahani S, Denkert C. Cutoff finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS ONE. 2012;7(12): e51862.","journal-title":"PLoS ONE"},{"issue":"7549","key":"5932_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332(7549):1080.","journal-title":"BMJ"},{"issue":"1","key":"5932_CR13","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/s41598-021-84787-5","volume":"11","author":"\u00c1 Nagy","year":"2021","unstructured":"Nagy \u00c1, Munk\u00e1csy G, Gy\u0151rffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021;11(1):6047.","journal-title":"Sci Rep"},{"issue":"1","key":"5932_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1373\/clinchem.2007.096529","volume":"54","author":"NR Cook","year":"2008","unstructured":"Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54(1):17\u201323.","journal-title":"Clin Chem"},{"issue":"5","key":"5932_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.105.594929","volume":"115","author":"KH Zou","year":"2007","unstructured":"Zou KH, O\u2019Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007;115(5):654\u20137.","journal-title":"Circulation"},{"issue":"1","key":"5932_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/bib\/bbr008","volume":"13","author":"D Berrar","year":"2012","unstructured":"Berrar D, Flach P. Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them). Brief Bioinform. 2012;13(1):83\u201397.","journal-title":"Brief Bioinform"},{"issue":"6","key":"5932_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/COH.0b013e32833ed742","volume":"5","author":"B Grund","year":"2010","unstructured":"Grund B, Sabin C. Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Curr Opin HIV AIDS. 2010;5(6):473\u20139.","journal-title":"Curr Opin HIV AIDS"},{"key":"5932_CR18","doi-asserted-by":"publisher","first-page":"1302811","DOI":"10.1155\/2021\/1302811","volume":"2021","author":"S Abd ElHafeez","year":"2021","unstructured":"Abd ElHafeez S, D\u2019Arrigo G, Leonardis D, Fusaro M, Tripepi G, Roumeliotis S. Methods to analyze time-to-event data: the cox regression analysis. Oxid Med Cell Longev. 2021;2021:1302811.","journal-title":"Oxid Med Cell Longev"},{"issue":"14","key":"5932_CR19","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jama.2020.1267","volume":"323","author":"MJ Stensrud","year":"2020","unstructured":"Stensrud MJ, Hern\u00e1n MA. Why test for proportional hazards? JAMA. 2020;323(14):1401\u20132.","journal-title":"JAMA"},{"issue":"12","key":"5932_CR20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41416-018-0302-8","volume":"119","author":"E Rulli","year":"2018","unstructured":"Rulli E, Ghilotti F, Biagioli E, Porcu L, Marabese M, D\u2019Incalci M, Bellocco R, Torri V. Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint. Br J Cancer. 2018;119(12):1456\u201363.","journal-title":"Br J Cancer"},{"issue":"7","key":"5932_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"TCGA","year":"2017","unstructured":"TCGA. GA Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327\u201341.","journal-title":"Cell"},{"issue":"5","key":"5932_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"2","key":"5932_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1086\/341527","volume":"71","author":"BV North","year":"2002","unstructured":"North BV, Curtis D, Sham PC. A note on the calculation of empirical P values from Monte Carlo procedures. Am J Hum Genet. 2002;71(2):439\u201341.","journal-title":"Am J Hum Genet"},{"key":"5932_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12935-020-01294-9","volume":"20","author":"G Ouyang","year":"2020","unstructured":"Ouyang G, Yi B, Pan G, Chen X. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma. Cancer Cell Int. 2020;20:207.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"5932_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67(8):850\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"5932_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"5932_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.326","volume":"5","author":"P Meng","year":"2014","unstructured":"Meng P, Ghosh R. Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy? Cell Death Dis. 2014;5(8): e1360.","journal-title":"Cell Death Dis"},{"key":"5932_CR28","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2147\/CMAR.S182001","volume":"11","author":"YL Huang","year":"2019","unstructured":"Huang YL, Ning G, Chen LB, Lian YF, Gu YR, Wang JL, Chen DM, Wei H, Huang YH. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma. Cancer Manag Res. 2019;11:1725\u201340.","journal-title":"Cancer Manag Res"},{"key":"5932_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2288-12-82","volume":"12","author":"PC Austin","year":"2012","unstructured":"Austin PC, Steyerberg EW. Interpreting the concordance statistic of a logistic regression model: relation to the variance and odds ratio of a continuous explanatory variable. BMC Med Res Methodol. 2012;12:82.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"5932_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","volume":"17","author":"AN Kamarudin","year":"2017","unstructured":"Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"5932_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","volume":"171","author":"TCGA","year":"2017","unstructured":"TCGA. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell. 2017;171(4):950\u201365.","journal-title":"Cell"},{"issue":"2","key":"5932_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"TCGA","year":"2017","unstructured":"TCGA. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017;32(2):185\u2013203.","journal-title":"Cancer Cell"},{"issue":"2","key":"5932_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa1505917","volume":"374","author":"WM Linehan","year":"2016","unstructured":"Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135\u201345.","journal-title":"N Engl J Med"},{"issue":"26","key":"5932_CR34","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481\u201398.","journal-title":"N Engl J Med"},{"issue":"2","key":"5932_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41419-021-03405-4","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wang H, Xu J, Hou X, Zhan H, Zhen Y. Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma. Cell Death Dis. 2021;12(2):146.","journal-title":"Cell Death Dis"},{"issue":"3","key":"5932_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1399-0039.2007.00997.x","volume":"71","author":"MF Gjerstorff","year":"2008","unstructured":"Gjerstorff MF, Ditzel HJ. An overview of the GAGE cancer\/testis antigen family with the inclusion of newly identified members. Tissue Antigens. 2008;71(3):187\u201392.","journal-title":"Tissue Antigens"},{"issue":"4","key":"5932_CR37","doi-asserted-by":"publisher","first-page":"381.e381","DOI":"10.1016\/j.ajog.2018.12.030","volume":"220","author":"K Matsuo","year":"2019","unstructured":"Matsuo K, Purushotham S, Jiang B, Mandelbaum RS, Takiuchi T, Liu Y, Roman LD. Survival outcome prediction in cervical cancer: cox models vs deep-learning model. Am J Obstet Gynecol. 2019;220(4):381.e381-381.e314.","journal-title":"Am J Obstet Gynecol"},{"key":"5932_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12935-019-0858-2","volume":"19","author":"GM Liu","year":"2019","unstructured":"Liu GM, Zeng HD, Zhang CY, Xu JW. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19:138.","journal-title":"Cancer Cell Int"},{"key":"5932_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fcell.2020.00629","volume":"8","author":"T Zhou","year":"2020","unstructured":"Zhou T, Cai Z, Ma N, Xie W, Gao C, Huang M, Bai Y, Ni Y, Tang Y. A novel ten-gene signature predicting prognosis in hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:629.","journal-title":"Front Cell Dev Biol"},{"key":"5932_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841530","volume":"12","author":"R Chen","year":"2022","unstructured":"Chen R, Zhao M, An Y, Liu D, Tang Q, Teng G. A prognostic gene signature for hepatocellular carcinoma. Front Oncol. 2022;12: 841530.","journal-title":"Front Oncol"},{"issue":"5","key":"5932_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/cc2955","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick V, Cheek L, Ball J. Statistics review 12: survival analysis. Crit Care. 2004;8(5):389\u201394.","journal-title":"Crit Care"},{"issue":"1","key":"5932_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"2","key":"5932_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-9868.2011.01004.x","volume":"74","author":"R Tibshirani","year":"2012","unstructured":"Tibshirani R, Bien J, Friedman J, Hastie T, Simon N, Taylor J, Tibshirani RJ. Strong rules for discarding predictors in lasso-type problems. J R Stat Soc Ser B Stat Methodol. 2012;74(2):245\u201366.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"1","key":"5932_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1517\/17530059.2012.718329","volume":"7","author":"JE McDermott","year":"2013","unstructured":"McDermott JE, Wang J, Mitchell H, Webb-Robertson BJ, Hafen R, Ramey J, Rodland KD. Challenges in biomarker discovery: combining expert insights with statistical analysis of complex omics data. Expert Opin Med Diagn. 2013;7(1):37\u201351.","journal-title":"Expert Opin Med Diagn"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-024-05932-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-024-05932-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-024-05932-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T20:25:19Z","timestamp":1727468719000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-024-05932-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5932"],"URL":"https:\/\/doi.org\/10.1186\/s12859-024-05932-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"type":"electronic","value":"1471-2105"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"22 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}